Sandoz Incorporated FDA Inspection Record
Sandoz Incorporated is an FDA-inspected facility (FEI 1717759) located in East Hanover, NJ, US. RegDataLab tracks 8 FDA inspections and 1 compliance action at this facility.
What FDA found at this site
- Latest inspection
- Apr 16, 2019: Voluntary Action Indicated (VAI)
- Inspections on record
- 8 (1 OAI, 6 VAI, 1 NAI)
- Last OAI inspection
- May 6, 2011
- Warning letters
- 1 listed by FDA for this FEI, latest Nov 18, 2011
- Form 483 and inspection documents
- 1 in FDA's reading room
- Recalls as the recalling firm
- 35, latest Apr 6, 2018
- Import refusals
- 7
Inspections and what FDA cited
| Date | Result | What FDA cited |
|---|---|---|
| Apr 16, 2019 | Voluntary Action Indicated (VAI) | Cleaning / Sanitizing / Maintenance (21 CFR 211.67(a)) Lab controls established, including changes (21 CFR 211.160(a)) Investigations of discrepancies, failures (21 CFR 211.192) |
| Mar 29, 2017 | No Action Indicated (NAI) | No citations listed |
| Oct 30, 2015 | Voluntary Action Indicated (VAI) | No citations listed |
| Oct 17, 2013 | Voluntary Action Indicated (VAI) | Written procedures fail to include (21 CFR 211.67(b)) Written record of investigation incomplete (21 CFR 211.192) Late submission of 15-day report (21 CFR 314.80(c)(1)(i)) |
| Aug 14, 2012 | Voluntary Action Indicated (VAI) | No citations listed |
| May 6, 2011 | Official Action Indicated (OAI) | Authority lacking to review records, investigate errors (21 CFR 211.22(a)) Equipment Design, Size and Location (21 CFR 211.63) Cleaning / Sanitizing / Maintenance (21 CFR 211.67(a)) Rotation of components/containers/closures (21 CFR 211.86) and 7 more |
| May 28, 2010 | Voluntary Action Indicated (VAI) | No citations listed |
| Oct 8, 2008 | Voluntary Action Indicated (VAI) | Late submission of 15-day report (21 CFR 314.80(c)(1)(i)) |
Recalls
| Date | Class | Recall | Product and reason |
|---|---|---|---|
| Apr 6, 2018 | Class III | D-0631-2018 | Triamterene and Hydrochlorothiazide Tablets, USP, 75 mg/50 mg, 500-count bottles, Rx only… Cross Contamination With Other Products: presence of unrelated ingredients (i.e. traces of Lisinopril, Mannitol, Iron, Calcium and… |
| Jun 16, 2017 | Class III | D-0943-2017 | Amitriptyline HCl Tablets, USP 25 mg, Packaged in a)100-count bottles (NDC 0781-1487-01)… Cross Contamination With Other Product: Imipramine |
| Dec 22, 2016 | Class II | D-0236-2017 | Nadolol Tablets, USP, 40mg, packaged in 1000-count bottle, Rx Only, Manufactured by Sandoz… Failed dissolution specification: recalled due to an out of specification dissolution result of 40% (Specification: NLT 80%) |
| Dec 5, 2014 | Class III | D-0291-2015 | Fluoxetine Capsules USP, 20 mg, 100 count bottle, Rx Only, 100 Capsules, Sandoz Inc… Labeling: Illegible Label: Sandoz Inc. is recalling of one lot of Fluoxetine Capsules due to an illegible logo on the capsule. |
| Jul 25, 2014 | Class II | D-1509-2014 | Alprazolam Tablets, USP, 0.25mg, Rx only, 1000 tablets, Sandoz Inc., Princeton, NJ --- NDC… Presence of Foreign Substance; tablets may contain stainless steel metal particulates |
| Oct 22, 2013 | Class II | D-383-2014 | Tacrolimus Capsules, USP, 0.5 mg, 100 capsules/bottle, Rx only, Manufactured in India by… Cross Contamination with Other Products: findings of carryover of trace amounts of a previously manufactured product fluvastatin |
| Sep 25, 2013 | Class III | D-66373-001 | Hydroxychloroquine Sulfate Tablets, USP, 200 mg, Rx Only, 100 Tablets per bottle, Sandoz… Failed Tablet/Capsule Specifications: Sandoz is recalling one lot of Hydroxychloroquine Sulfate Tablets, USP, 200mg, due to illegibility of… |
| Aug 7, 2013 | Class III | D-854-2013 | Introvale (levonorgestrel and ethinyl estradiol) tablets, USP, 0.15 mg/0.03 mg, packaged… Contraceptive tablets out of sequence: Contraceptive tablets out of sequence: Introvale (levonorgestrel and ethinyl estradiol tablets USP… |
| Jun 21, 2013 | Class II | D-805-2013 | Estarylla (Norgestimate and Ethinyl Estradiol) Tablets. USP, 0.25mg/0.035mg, 3X28 tablets… Contraceptive Tablets out of Sequence: A placebo tablet was found in a row of active tablets. |
| May 30, 2013 | Class II | D-597-2013 | Cefazolin, injection, 1 gram per vial, 25 vials per box, sterile, Rx only, single-use… Lack of Assurance of Sterility: Sandoz Inc is recalling Cefazolin for Injection, USP 1 gm vials, lot DB2208, due to a customer complaint for… |
Form 483s and inspection documents
FDA record score
3 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.
23 records behind this number
| Record | Date | Points x age weight | Adds |
|---|---|---|---|
| Inspection classified VAI | Apr 16, 2019 | 6 x 0.25 | 1.5 |
| Class II recall D-0236-2017, this FEI as the recalling firm | Dec 22, 2016 | 4 x 0.25 | 1 |
| Inspection classified VAI | Oct 30, 2015 | 10 years or older, so it adds no points | 0 |
| Class II recall D-1509-2014, this FEI as the recalling firm | Jul 25, 2014 | 10 years or older, so it adds no points | 0 |
| Class II recall D-383-2014, this FEI as the recalling firm | Oct 22, 2013 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | Oct 17, 2013 | 10 years or older, so it adds no points | 0 |
| Class II recall D-805-2013, this FEI as the recalling firm | Jun 21, 2013 | 10 years or older, so it adds no points | 0 |
| Class II recall D-597-2013, this FEI as the recalling firm | May 30, 2013 | 10 years or older, so it adds no points | 0 |
| Class I recall D-832-2013, this FEI as the recalling firm | May 20, 2013 | 10 years or older, so it adds no points | 0 |
| Class II recall V-146-2013, this FEI as the recalling firm | Apr 22, 2013 | 10 years or older, so it adds no points | 0 |
| Class II recall D-268-2013, this FEI as the recalling firm | Apr 18, 2013 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | Aug 14, 2012 | 10 years or older, so it adds no points | 0 |
| Class II recall D-1249-2012, this FEI as the recalling firm | Jan 31, 2012 | 10 years or older, so it adds no points | 0 |
| Class II recall D-1170-2012, this FEI as the recalling firm | Jan 6, 2012 | 10 years or older, so it adds no points | 0 |
| Warning letter on FDA's dashboard, which does not show close-outs | Nov 18, 2011 | 10 years or older, so it adds no points | 0 |
| Inspection classified OAI | May 6, 2011 | 10 years or older, so it adds no points | 0 |
| Class II recall D-162-2011, this FEI as the recalling firm | Nov 18, 2010 | 10 years or older, so it adds no points | 0 |
| Class II recall D-204-2011, this FEI as the recalling firm | Nov 18, 2010 | 10 years or older, so it adds no points | 0 |
| Class II recall D-413-2011, this FEI as the recalling firm | Nov 10, 2010 | 10 years or older, so it adds no points | 0 |
| Class I recall D-130-2011, this FEI as the recalling firm | Oct 25, 2010 | 10 years or older, so it adds no points | 0 |
| Class II recall D-020-2011, this FEI as the recalling firm | Sep 24, 2010 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | May 28, 2010 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | Oct 8, 2008 | 10 years or older, so it adds no points | 0 |
When each source was last refreshed
| Records | Last refreshed | Source as of | Status |
|---|---|---|---|
| Inspections | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Inspection citations | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions (warning letters, injunctions and other action types) | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
| Warning letter text | Nov 16, 2026 | Newest record Nov 10, 2026 | Current |
| Recalls (Enforcement Report) | Nov 16, 2026 | Newest record Nov 11, 2026 | Current |
| Form 483s and inspection documents | Nov 13, 2026 | Newest record Nov 12, 2026 | Current |
| Import refusals | Nov 15, 2026 | Newest record Nov 5, 2026 | Current |
Reviewing Sandoz Incorporated as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Sandoz Incorporated yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Facility details
- Company
- Sandoz Incorporated
- Location
- East Hanover, NJ (US)
- Source
- inspections